sars cov 1 strain 229e Search Results


sars cov 1 strain 229e  (ATCC)
92
ATCC sars cov 1 strain 229e
Sars Cov 1 Strain 229e, supplied by ATCC, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sars cov 1 strain 229e/product/ATCC
Average 92 stars, based on 1 article reviews
sars cov 1 strain 229e - by Bioz Stars, 2026-04
92/100 stars
  Buy from Supplier
sars cov 1 spike  (Sino Biological)
95
Sino Biological sars cov 1 spike
Sars Cov 1 Spike, supplied by Sino Biological, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sars cov 1 spike/product/Sino Biological
Average 95 stars, based on 1 article reviews
sars cov 1 spike - by Bioz Stars, 2026-04
95/100 stars
  Buy from Supplier
synthetic controls  (Twist Bioscience)
90
Twist Bioscience synthetic controls
Synthetic Controls, supplied by Twist Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/synthetic controls/product/Twist Bioscience
Average 90 stars, based on 1 article reviews
synthetic controls - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
sars cov 2  (BPS Bioscience)
93
BPS Bioscience sars cov 2
a Number of patients recruited in the DRASTIC cohort and samples collected (top panel) and days post disease onset of COVID-19 blood samples (bottom panel). b Collection timepoints of respiratory samples (endotracheal tube aspirate (ETA), sputum, and pleural fluid) and paired blood samples from the same patients (left panel). Comparison of days post disease onset between blood and respiratory samples for COVID-19 and non-COVID-19 patients (right panel) using Mann-Whitney test. c Maximum likelihood phylogenetic tree of <t>SARS-CoV-2</t> sequences from Victoria from 28 January 2020 to 28 October 2020 (including context sequences from rest of Australia and New Zealand). Phylogenetic tree includes randomly subsampled sequences from transmission networks (TN) A and TN B in Victoria, with a total number of 10941 and 145 cases respectively. The outermost tip of each radial line represents a single sequence; the sum of each radial line between two tips represents the genetic distance between two sequences. Each radial stepwise progression represents approximately one single nucleotide polymorphism (SNP). Sequences from study patients are shown as open circles (patient with blood samples only) or solid-coloured circles (patients with blood and respiratory samples, same colours as in section b). Half-filled circles are used when samples are located close to each other. d Distribution of clinical data in ward and intensive care unit (ICU) COVID-19 patients. Box and bars indicate first and third quartiles, and range respectively. Statistical significance was determined with the Fisher’s exact test for the National Institutes of Health (NIH) score, and Mann-Whitney test for age, weight, height, and body weight index (BMI). Correlation was determined with Spearman’s correlation.
Sars Cov 2, supplied by BPS Bioscience, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sars cov 2/product/BPS Bioscience
Average 93 stars, based on 1 article reviews
sars cov 2 - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier
sars cov 1  (ATCC)
98
ATCC sars cov 1
a Number of patients recruited in the DRASTIC cohort and samples collected (top panel) and days post disease onset of COVID-19 blood samples (bottom panel). b Collection timepoints of respiratory samples (endotracheal tube aspirate (ETA), sputum, and pleural fluid) and paired blood samples from the same patients (left panel). Comparison of days post disease onset between blood and respiratory samples for COVID-19 and non-COVID-19 patients (right panel) using Mann-Whitney test. c Maximum likelihood phylogenetic tree of <t>SARS-CoV-2</t> sequences from Victoria from 28 January 2020 to 28 October 2020 (including context sequences from rest of Australia and New Zealand). Phylogenetic tree includes randomly subsampled sequences from transmission networks (TN) A and TN B in Victoria, with a total number of 10941 and 145 cases respectively. The outermost tip of each radial line represents a single sequence; the sum of each radial line between two tips represents the genetic distance between two sequences. Each radial stepwise progression represents approximately one single nucleotide polymorphism (SNP). Sequences from study patients are shown as open circles (patient with blood samples only) or solid-coloured circles (patients with blood and respiratory samples, same colours as in section b). Half-filled circles are used when samples are located close to each other. d Distribution of clinical data in ward and intensive care unit (ICU) COVID-19 patients. Box and bars indicate first and third quartiles, and range respectively. Statistical significance was determined with the Fisher’s exact test for the National Institutes of Health (NIH) score, and Mann-Whitney test for age, weight, height, and body weight index (BMI). Correlation was determined with Spearman’s correlation.
Sars Cov 1, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sars cov 1/product/ATCC
Average 98 stars, based on 1 article reviews
sars cov 1 - by Bioz Stars, 2026-04
98/100 stars
  Buy from Supplier
sars cov 1 antigen  (Native Antigen Inc)
86
Native Antigen Inc sars cov 1 antigen
a Number of patients recruited in the DRASTIC cohort and samples collected (top panel) and days post disease onset of COVID-19 blood samples (bottom panel). b Collection timepoints of respiratory samples (endotracheal tube aspirate (ETA), sputum, and pleural fluid) and paired blood samples from the same patients (left panel). Comparison of days post disease onset between blood and respiratory samples for COVID-19 and non-COVID-19 patients (right panel) using Mann-Whitney test. c Maximum likelihood phylogenetic tree of <t>SARS-CoV-2</t> sequences from Victoria from 28 January 2020 to 28 October 2020 (including context sequences from rest of Australia and New Zealand). Phylogenetic tree includes randomly subsampled sequences from transmission networks (TN) A and TN B in Victoria, with a total number of 10941 and 145 cases respectively. The outermost tip of each radial line represents a single sequence; the sum of each radial line between two tips represents the genetic distance between two sequences. Each radial stepwise progression represents approximately one single nucleotide polymorphism (SNP). Sequences from study patients are shown as open circles (patient with blood samples only) or solid-coloured circles (patients with blood and respiratory samples, same colours as in section b). Half-filled circles are used when samples are located close to each other. d Distribution of clinical data in ward and intensive care unit (ICU) COVID-19 patients. Box and bars indicate first and third quartiles, and range respectively. Statistical significance was determined with the Fisher’s exact test for the National Institutes of Health (NIH) score, and Mann-Whitney test for age, weight, height, and body weight index (BMI). Correlation was determined with Spearman’s correlation.
Sars Cov 1 Antigen, supplied by Native Antigen Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sars cov 1 antigen/product/Native Antigen Inc
Average 86 stars, based on 1 article reviews
sars cov 1 antigen - by Bioz Stars, 2026-04
86/100 stars
  Buy from Supplier
plpro from seven coronaviruses  (Databank Inc)
90
Databank Inc plpro from seven coronaviruses
a Number of patients recruited in the DRASTIC cohort and samples collected (top panel) and days post disease onset of COVID-19 blood samples (bottom panel). b Collection timepoints of respiratory samples (endotracheal tube aspirate (ETA), sputum, and pleural fluid) and paired blood samples from the same patients (left panel). Comparison of days post disease onset between blood and respiratory samples for COVID-19 and non-COVID-19 patients (right panel) using Mann-Whitney test. c Maximum likelihood phylogenetic tree of <t>SARS-CoV-2</t> sequences from Victoria from 28 January 2020 to 28 October 2020 (including context sequences from rest of Australia and New Zealand). Phylogenetic tree includes randomly subsampled sequences from transmission networks (TN) A and TN B in Victoria, with a total number of 10941 and 145 cases respectively. The outermost tip of each radial line represents a single sequence; the sum of each radial line between two tips represents the genetic distance between two sequences. Each radial stepwise progression represents approximately one single nucleotide polymorphism (SNP). Sequences from study patients are shown as open circles (patient with blood samples only) or solid-coloured circles (patients with blood and respiratory samples, same colours as in section b). Half-filled circles are used when samples are located close to each other. d Distribution of clinical data in ward and intensive care unit (ICU) COVID-19 patients. Box and bars indicate first and third quartiles, and range respectively. Statistical significance was determined with the Fisher’s exact test for the National Institutes of Health (NIH) score, and Mann-Whitney test for age, weight, height, and body weight index (BMI). Correlation was determined with Spearman’s correlation.
Plpro From Seven Coronaviruses, supplied by Databank Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/plpro from seven coronaviruses/product/Databank Inc
Average 90 stars, based on 1 article reviews
plpro from seven coronaviruses - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


a Number of patients recruited in the DRASTIC cohort and samples collected (top panel) and days post disease onset of COVID-19 blood samples (bottom panel). b Collection timepoints of respiratory samples (endotracheal tube aspirate (ETA), sputum, and pleural fluid) and paired blood samples from the same patients (left panel). Comparison of days post disease onset between blood and respiratory samples for COVID-19 and non-COVID-19 patients (right panel) using Mann-Whitney test. c Maximum likelihood phylogenetic tree of SARS-CoV-2 sequences from Victoria from 28 January 2020 to 28 October 2020 (including context sequences from rest of Australia and New Zealand). Phylogenetic tree includes randomly subsampled sequences from transmission networks (TN) A and TN B in Victoria, with a total number of 10941 and 145 cases respectively. The outermost tip of each radial line represents a single sequence; the sum of each radial line between two tips represents the genetic distance between two sequences. Each radial stepwise progression represents approximately one single nucleotide polymorphism (SNP). Sequences from study patients are shown as open circles (patient with blood samples only) or solid-coloured circles (patients with blood and respiratory samples, same colours as in section b). Half-filled circles are used when samples are located close to each other. d Distribution of clinical data in ward and intensive care unit (ICU) COVID-19 patients. Box and bars indicate first and third quartiles, and range respectively. Statistical significance was determined with the Fisher’s exact test for the National Institutes of Health (NIH) score, and Mann-Whitney test for age, weight, height, and body weight index (BMI). Correlation was determined with Spearman’s correlation.

Journal: medRxiv

Article Title: Immune responses in COVID-19 respiratory tract and blood reveal mechanisms of disease severity

doi: 10.1101/2021.09.01.21262715

Figure Lengend Snippet: a Number of patients recruited in the DRASTIC cohort and samples collected (top panel) and days post disease onset of COVID-19 blood samples (bottom panel). b Collection timepoints of respiratory samples (endotracheal tube aspirate (ETA), sputum, and pleural fluid) and paired blood samples from the same patients (left panel). Comparison of days post disease onset between blood and respiratory samples for COVID-19 and non-COVID-19 patients (right panel) using Mann-Whitney test. c Maximum likelihood phylogenetic tree of SARS-CoV-2 sequences from Victoria from 28 January 2020 to 28 October 2020 (including context sequences from rest of Australia and New Zealand). Phylogenetic tree includes randomly subsampled sequences from transmission networks (TN) A and TN B in Victoria, with a total number of 10941 and 145 cases respectively. The outermost tip of each radial line represents a single sequence; the sum of each radial line between two tips represents the genetic distance between two sequences. Each radial stepwise progression represents approximately one single nucleotide polymorphism (SNP). Sequences from study patients are shown as open circles (patient with blood samples only) or solid-coloured circles (patients with blood and respiratory samples, same colours as in section b). Half-filled circles are used when samples are located close to each other. d Distribution of clinical data in ward and intensive care unit (ICU) COVID-19 patients. Box and bars indicate first and third quartiles, and range respectively. Statistical significance was determined with the Fisher’s exact test for the National Institutes of Health (NIH) score, and Mann-Whitney test for age, weight, height, and body weight index (BMI). Correlation was determined with Spearman’s correlation.

Article Snippet: In addition, SARS-CoV-2 and HKU-1 spike trimers (kind gifts from Adam K. Wheatley), as well as SARS-CoV and NL63 spike trimers (BPS Bioscience) were also coupled.

Techniques: MANN-WHITNEY, Transmission Assay, Sequencing

a ELISA titration curves against the SARS-CoV-2 receptor-binding domain (RBD) for IgM, IgG, and IgA in COVID-19 respiratory and paired blood samples and non-COVID-19 respiratory samples. Dotted lines within each graph indicates the cut-off used to determine end-point titres. b End-point titres of SARS-CoV-2 RBD antibodies between (i) respiratory samples of COVID-19 and non-COVID-19 patients, and (ii) plasma and respiratory samples of COVID-19 patients. (i) Bars indicate median with interquartile range. Dotted line indicates the detection level. (ii) Dotted lines connect the most closely matched plasma and respiratory samples from each patient. Statistical significance was determined with Mann-Whitney test. c ELISA titration curves against the SARS-CoV-2 RBD for 3 COVID-19 patients with serial respiratory samples. d Heatmap of percentage (%) inhibition tested by surrogate virus neutralization test (sVNT) and anti-RBD ELISA titres. e Correlation between anti-RBD antibody titres and (%) sVNT inhibition. Correlation was determined with Spearman’s correlation. f Number of (i) samples and (ii) patients with seroconverted anti-RBD IgM, IgG, IgA and positive % sVNT inhibition. Pink curved lines surrounding the donut graphs indicate the samples/patients with seroconverted IgM. Earliest samples were used for each patient when determining seroconversion which was defined as average titre +2×SD of non-COVID-19 samples. Positive % sVNT inhibition was defined as % sVNT inhibition ≥ 20%.

Journal: medRxiv

Article Title: Immune responses in COVID-19 respiratory tract and blood reveal mechanisms of disease severity

doi: 10.1101/2021.09.01.21262715

Figure Lengend Snippet: a ELISA titration curves against the SARS-CoV-2 receptor-binding domain (RBD) for IgM, IgG, and IgA in COVID-19 respiratory and paired blood samples and non-COVID-19 respiratory samples. Dotted lines within each graph indicates the cut-off used to determine end-point titres. b End-point titres of SARS-CoV-2 RBD antibodies between (i) respiratory samples of COVID-19 and non-COVID-19 patients, and (ii) plasma and respiratory samples of COVID-19 patients. (i) Bars indicate median with interquartile range. Dotted line indicates the detection level. (ii) Dotted lines connect the most closely matched plasma and respiratory samples from each patient. Statistical significance was determined with Mann-Whitney test. c ELISA titration curves against the SARS-CoV-2 RBD for 3 COVID-19 patients with serial respiratory samples. d Heatmap of percentage (%) inhibition tested by surrogate virus neutralization test (sVNT) and anti-RBD ELISA titres. e Correlation between anti-RBD antibody titres and (%) sVNT inhibition. Correlation was determined with Spearman’s correlation. f Number of (i) samples and (ii) patients with seroconverted anti-RBD IgM, IgG, IgA and positive % sVNT inhibition. Pink curved lines surrounding the donut graphs indicate the samples/patients with seroconverted IgM. Earliest samples were used for each patient when determining seroconversion which was defined as average titre +2×SD of non-COVID-19 samples. Positive % sVNT inhibition was defined as % sVNT inhibition ≥ 20%.

Article Snippet: In addition, SARS-CoV-2 and HKU-1 spike trimers (kind gifts from Adam K. Wheatley), as well as SARS-CoV and NL63 spike trimers (BPS Bioscience) were also coupled.

Techniques: Enzyme-linked Immunosorbent Assay, Titration, Binding Assay, MANN-WHITNEY, Inhibition, Neutralization

a Heatmaps with unsupervised clustering of SARS-CoV-2-specific antibodies in COVID-19 respiratory and plasma samples. b median fluorescence intensity of IgM, IgG, IgA1, and IgA2 antibodies between COVID-19 and non-COVID-19 respiratory samples. Statistical significance was determined with Mann-Whitney test. c Partial Least-Squares Discriminant Analysis (PLSDA) scores and loading plots of ETA and plasma from five COVID-19 and five non-COVID-19 patients with the smallest difference in days post disease onset between ETA and plasma samples.

Journal: medRxiv

Article Title: Immune responses in COVID-19 respiratory tract and blood reveal mechanisms of disease severity

doi: 10.1101/2021.09.01.21262715

Figure Lengend Snippet: a Heatmaps with unsupervised clustering of SARS-CoV-2-specific antibodies in COVID-19 respiratory and plasma samples. b median fluorescence intensity of IgM, IgG, IgA1, and IgA2 antibodies between COVID-19 and non-COVID-19 respiratory samples. Statistical significance was determined with Mann-Whitney test. c Partial Least-Squares Discriminant Analysis (PLSDA) scores and loading plots of ETA and plasma from five COVID-19 and five non-COVID-19 patients with the smallest difference in days post disease onset between ETA and plasma samples.

Article Snippet: In addition, SARS-CoV-2 and HKU-1 spike trimers (kind gifts from Adam K. Wheatley), as well as SARS-CoV and NL63 spike trimers (BPS Bioscience) were also coupled.

Techniques: Fluorescence, MANN-WHITNEY